Sieminska I, Pieniawska M, Grzywa T
Clin Rev Allergy Immunol. 2024; 66(2):164-191.
PMID: 38642273
PMC: 11193704.
DOI: 10.1007/s12016-024-08991-7.
Teo W, Lim Y, Sio Y, Say Y, Reginald K, Chew F
World Allergy Organ J. 2024; 17(2):100869.
PMID: 38298829
PMC: 10827559.
DOI: 10.1016/j.waojou.2023.100869.
Guo J, Zhang H, Lin W, Lu L, Su J, Chen X
Signal Transduct Target Ther. 2023; 8(1):437.
PMID: 38008779
PMC: 10679229.
DOI: 10.1038/s41392-023-01655-6.
Mylonas A, Hawerkamp H, Wang Y, Chen J, Messina F, Demaria O
JCI Insight. 2023; 8(4).
PMID: 36633910
PMC: 9977509.
DOI: 10.1172/jci.insight.151846.
Shi L, Liu C, Xiong H, Shi D
Front Med (Lausanne). 2022; 9:1007892.
PMID: 36314037
PMC: 9606585.
DOI: 10.3389/fmed.2022.1007892.
The Role of T Helper 22 Cells in Dermatological Disorders.
Pan Y, Du D, Wang L, Wang X, He G, Jiang X
Front Immunol. 2022; 13:911546.
PMID: 35911703
PMC: 9331286.
DOI: 10.3389/fimmu.2022.911546.
Dendritic Cells and Macrophages in the Pathogenesis of Psoriasis.
Kamata M, Tada Y
Front Immunol. 2022; 13:941071.
PMID: 35837394
PMC: 9274091.
DOI: 10.3389/fimmu.2022.941071.
Orchestrated Cytokines Mediated by Biologics in Psoriasis and Its Mechanisms of Action.
Noor A, Azlan M, Mohd Redzwan N
Biomedicines. 2022; 10(2).
PMID: 35203707
PMC: 8962336.
DOI: 10.3390/biomedicines10020498.
Skin Barrier Dysregulation in Psoriasis.
Orsmond A, Bereza-Malcolm L, Lynch T, March L, Xue M
Int J Mol Sci. 2021; 22(19).
PMID: 34639182
PMC: 8509518.
DOI: 10.3390/ijms221910841.
Advances in the Application of Natural Products and the Novel Drug Delivery Systems for Psoriasis.
Xie J, Huang S, Huang H, Deng X, Yue P, Lin J
Front Pharmacol. 2021; 12:644952.
PMID: 33967781
PMC: 8097153.
DOI: 10.3389/fphar.2021.644952.
Protein and mRNA Expression Levels of Interleukin-17A, -17F and -22 in Blood and Skin Samples of Patients with Mycosis Fungoides.
Papathemeli D, Patsatsi A, Papanastassiou D, Koletsa T, Papathemelis T, Avgeros C
Acta Derm Venereol. 2020; 100(18):adv00326.
PMID: 33170303
PMC: 9309846.
DOI: 10.2340/00015555-3688.
New Treatment Addressing the Pathogenesis of Psoriasis.
Tokuyama M, Mabuchi T
Int J Mol Sci. 2020; 21(20).
PMID: 33050592
PMC: 7589905.
DOI: 10.3390/ijms21207488.
The commensal skin microbiota triggers type I IFN-dependent innate repair responses in injured skin.
Di Domizio J, Belkhodja C, Chenuet P, Fries A, Murray T, Mondejar P
Nat Immunol. 2020; 21(9):1034-1045.
PMID: 32661363
DOI: 10.1038/s41590-020-0721-6.
A peptide derived from phage-display limits psoriasis-like lesions in mice.
Zapi-Colin L, Gutierrez-Gonzalez G, Rodriguez-Martinez S, Cancino-Diaz J, Mendez-Tenorio A, Perez-Tapia S
Heliyon. 2020; 6(6):e04162.
PMID: 32577560
PMC: 7304002.
DOI: 10.1016/j.heliyon.2020.e04162.
IL-6 Negatively Regulates IL-22R Expression on Epidermal Keratinocytes: Implications for Irritant Contact Dermatitis.
Frempah B, Luckett-Chastain L, Gallucci R
J Immunol Res. 2019; 2019:6276254.
PMID: 31781680
PMC: 6875369.
DOI: 10.1155/2019/6276254.
Eczematous eruption after guselkumab treatment for psoriasis.
Reyn B, Hillary T, Gils A
JAAD Case Rep. 2019; 5(11):973-975.
PMID: 31687468
PMC: 6820255.
DOI: 10.1016/j.jdcr.2019.09.005.
Type1 Interferons Potential Initiating Factors Linking Skin Wounds With Psoriasis Pathogenesis.
Zhang L
Front Immunol. 2019; 10:1440.
PMID: 31293591
PMC: 6603083.
DOI: 10.3389/fimmu.2019.01440.
Anti-IL-22 Antibody Attenuates Acute Graft-versus-Host Disease via Increasing Foxp3 T Cell through Modulation of CD11b Cell Function.
Wu J, Gu J, Zhou S, Lu H, Lu Y, Lu L
J Immunol Res. 2018; 2018:1605341.
PMID: 30159338
PMC: 6109487.
DOI: 10.1155/2018/1605341.
The pathogenic role of interleukin-22 and its receptor during UVB-induced skin inflammation.
Kim Y, Lee J, Kim J, Choi C, Hwang Y, Kang J
PLoS One. 2017; 12(5):e0178567.
PMID: 28558005
PMC: 5448782.
DOI: 10.1371/journal.pone.0178567.
Epidermal CD147 expression plays a key role in IL-22-induced psoriatic dermatitis.
Peng C, Zhang S, Lei L, Zhang X, Jia X, Luo Z
Sci Rep. 2017; 7:44172.
PMID: 28272440
PMC: 5341158.
DOI: 10.1038/srep44172.
